Cash & equivalents increased 18.1%
Cash & equivalents changed +18.1% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +18.1% from the comparable as-filed period.
Revenue changed +10.8% from the comparable as-filed period.
Stock-based compensation changed -21.3% from the comparable as-filed period.
Gross margin changed -11 basis points from the comparable as-filed period.
Gross profit changed +10.6% from the comparable as-filed period.
Research & development changed +8.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.